Regular assessment and improvement of healthcare quality can reduce the burden of chronic diseases on patients as well as healthcare staff. Inflammatory bowel disease (IBD) causes a significant burden on hospitalization corresponding to rehospitalization on both patients and healthcare facility, discloses a study published in Therapeutic Advances in Gastroenterology, SAGE Journals.
#WorldIBDDay2020 was all about wellbeing for us, and @CICRAcharity have released some great resources to help young people and those around them live well with Crohn's and Colitis.https://t.co/dmSTNbEOla#mentalhealth #mentalhealthawareness #wellbeing #ittakesgutstotalk
— Crohn's & Colitis UK (@CrohnsColitisUK) May 20, 2020
This #WorldIBDDay, our Talking Toolkit is here to help!
— Crohn's & Colitis UK (@CrohnsColitisUK) May 19, 2020
The study emphasizes that there is a dire need to reduce rehospitalization due to IBD and new interventions must be made to improve the quality care which will subsequently reduce IBD burden on hospitals in addition to patients.
Inflammatory bowel disease is a term used for group of diseases that affects digestive system and cause chronic inflammation in stomach resulting in sores and ulcers in intestines and stomach. Ulcerative colitis (UC) and Crohn’s disease (CD) are the two main types of diseases of inflammatory bowel disease, states CDC. IBD affects more than 5 million people worldwide and health burden of IBD costs more than €30 billion. In 2015, it was estimated that more than 3 million of US adults were diagnosed with IBD. It was a massive increase of 2 million adults from 1999.
Inflammatory bowel disease (IBD) is a term for two conditions (Crohn’s disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal (GI) tract prolonged inflammation results in damage to the GI tract, CDC.
The study was conducted by researchers of Portuguese Inflammatory Bowel Disease (IBD) Study Group (GEDII), Portugal. It is a 16-year old retrospective study which did analysis of hospitalization and discharge of patients affected with IBD diseases during the time of 2000 and 2015 in mainland Portugal. The analysed data was retrieved from the national registry of the Central Administration of the Health System (ACSS).
The study evaluated and followed the rates of rehospitalization, respective charges, and associated risk factor for over 16 years to determine rehospitalization burden on patients with IBD and on quality care in infirmaries. Data collected included all the information regarding patients, expenses including clinical, healthcare, and medication bills.
Results showed that over 15,931 out of 48,027 IBD patients were subjected to rehospitalization during 16 years constituting 33% of proportion which was expected to increase by 12%. Yet, 2.5-fold decrease in rehospitalization of 100,000 IBD patients was observed between 2003 to 2015 from 6101 to 2421. In 2000, rehospitalization charges relating to IBD were €14,589 per hospitalization per year and it was recorded €17,548 per hospitalization per year in 2015. The overall hospitalization charges reached €3.1 million per year by 2015, according to the study logs. The study recorded rehospitalization rates for 30 day: 22.4% for Ulcerative Colitis and 24% for Crohn’s disease
The aforementioned stats represent the economic burden of rehospitalization on patients and quality care in hospitals in mainland Portugal. The study is a good intervention to identify risk factors of IBD related rehospitalization. It will open ways for potential revisions and improvements in healthcare system in future which will ultimately reduce the estimated burden due to rehospitalization.
— CDC Genomics & Precision Health (@CDC_Genomics) January 24, 2015